Vice President and Principal Investigator at 3Bs Institute, Postgraduate in Biomedical Eng., PhD in Materials Science and Technology, Tissue and Hybrid Materials Eng. at Universidade do Minho
Miguel Oliveira is a Principal Investigator “Investigador FCT 2012 and Investigador FCT 2015” at the PT Government Associate Laboratory ICVS/3B’s. He is the Vice President of I3Bs – Institute 3B’s (Univ. Minho) and Director of Pre-Clinical Research at the FIFA MEDICAL CENTER, Estádio do Dragão, Porto, PT since Feb. 2013.
Currently, he is a Lecturer in Doctoral Program in Tissue Engineering, Regenerative Medicine and Stem Cells (TERM&SC) at UMinho, PT (since Dec. 2013). He was also an invited lecturer at the Faculty of Medicine, U. Porto (2013-2019) and Dept. of Polymer Eng., UM, PT (2009-present). Over the years he has focused his work on the field of biomaterials for tissue engineering, nanomedicine, stem cells, and cell/drug delivery.
More recently, he set up a new research line within the ICVS/3B’s on 3D in vitro models for cancer research. As a result of his proficiency, he has published so far more than 300 scientific contributions in scientific journals with the referee, being 4 of those review papers produced under invitation.
Miguel Oliveira has approved more than 20 patents (filled & submitted), published 6 books (plus 2 in preparation), 5 special issues in scientific journals, and more than 90 book chapters in books with international circulation. He has participated in more than 500 communications in national/international conferences and has been invited/keynote speaker in more than 50 plenary sessions.
He has an h-index of 46, i10 of 144 and received more than 8300 citations. He has been awarded several prizes including the prestigious Jean Leray Award 2015 from European Society for Biomaterials for Young Scientists for Outstanding Contributions within the field of Biomaterials.
Miguel Oliveira is very active on the elaboration and scientific coordination of several PT and international funded projects. In addition, he is member of the National Ethics Committee for Clinical Trials from Serviço Nacional de Saúde (SNS) (PORTUGAL). He also integrates the advisory /editorial board of the Journal Bio-Design and Manufacturing, Journal of Materials Science: Materials in Medicine, Materials (MDPI), International Journal of Tissue Engineering, Journal ISRN Biomaterials, The Journal of Experimental Orthopaedics, Journal “Recent Patents on Corrosion Science”, and referee in more than 50 international journals. In 2020, he was listed among the TOP50 worldwide experts in tissue engineering by EXPERTSCAPE.